One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put AMAG Pharmaceuticals, Inc. AMAG stock into this equation and find out if it …
The sale price, which is a mix of cash and stock, may rise to more than $1.1 billion if certain sales milestones are reached, Chesterfield-based Lumara Health said Monday. Amag Pharmaceuticals, based in Waltham, Mass., is …
The top pre-market NASDAQ stock market gainers are: Voltaire, AMAG Pharmaceuticals, Sangamo Biosciences, Netlist, Avanir Pharmaceuticals, Netflix, Deckers Outdoor, Amazon.com, JA Solar Holdings, Baidu, and Apple. Voltaire …
The technology company had a solid second quarter and said it will buy back $25 billion in stock. The food company said its snacks business struggled and forecast a smaller-than-expected profit. AMAG Pharmaceuticals Inc., up $4.05 to …
Five analysts surveyed by Zacks expected $166.8 million. AMAG Pharmaceuticals shares have fallen 62 percent since the beginning of the year. The stock has decreased 50 percent in the last 12 months. This story was generated by …
Yahoo!3mon
Amag Pharmaceuticals is buying the maternal health business of Lumara Health to get access to the big-selling premature birth drug Makena. The company is forking out $675 million ($600 million in cash and $75 million in stock) …
The analyst believes that the acquisition of Cord Blood Registry (CBR) not only helps diversify AMAG Pharmaceuticals' revenue base, it also offers robust support to the stock. "While AMAG continues to rely on acquisitions for …
Jones has also experienced a tough 2017 with his fund's position in AMAG Pharmaceuticals. The biotech's stock is down around 35% so far this year. AMAG's problems started in January when the company announced its fourth-quarter …